QT
MNTA

Quantamental Technologies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Quantamental Technologies’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,604
Closed -$32K – 1957
2019
Q2 		$32K Sell
2,604
-2,058
-44% -$27.3K 0.01% 1047
2019
Q1 		$68K Buy
+4,662
New +$59.5K 0.03% 752

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Quantamental Technologies's MNTA Position: Q3 2019 in Review

Quantamental Technologies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 2,604 shares — an estimated $32K sold.

Quantamental Technologies first reported a position in MNTA in Q1 2019 and held it in 2 quarters. The position peaked at $68K in Q1 2019. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

  • Quantamental Technologies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 2,604 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $32K.
  • Quantamental Technologies first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 2 quarters.
  • Quantamental Technologies's Momenta Pharmaceuticals, Inc. position peaked at $68K in Q1 2019.
  • 154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.